Bengaluru-based healthcare screening technology provider Cardiotrack has announced a significant milestone in its journey towards revolutionizing the healthcare industry. The company has successfully secured US$2 million in pre-Series A funding, led by seasoned angel investor Girish Narasimhan, along with a group of investors including Y S Shashidhar.

This latest round of funding is a testament to Cardiotrack’s innovative approach to healthcare screening, which focuses on delivering comprehensive, convenient, and personalized services to health and life insurance providers and their customers. The investment will enable Cardiotrack to expand its solutions further, reaching more insurance providers and enhancing the accessibility and efficiency of healthcare screening for individuals across India and beyond.

Cardiotrack’s technology enables at-home pathology and radiology screening services, with a network spanning over 300 locations in India. The company’s unique screening technologies include the equivalent of a treadmill test conducted in the comfort of one’s home, along with video-based recorded medical examinations. This approach not only enhances convenience for consumers but also enables insurance providers to offer fast, comprehensive, and personalized services.

Commenting on the funding, Avin Agarwal, Founder & CEO of Cardiotrack, expressed excitement about the investment and reiterated the company’s commitment to driving positive change in the healthcare industry. He emphasized Cardiotrack’s mission to empower individuals to take control of their health while enabling insurance providers to offer seamless onboarding experiences and improve operational efficiency.

Girish Narasimhan, a seasoned angel investor and Member of the Board at Cardiotrack, praised the company’s dedication to revolutionizing healthcare screening and highlighted its strong market validation through partnerships with leading health and life insurance providers. He expressed confidence in Cardiotrack’s ability to cement its position among startups reshaping the future of healthcare.

With this pre-Series A funding, Cardiotrack is poised to strengthen its position as a leading provider of cutting-edge healthcare screening technology and services. The company’s commitment to innovation and collaboration underscores its vision to make healthcare screening more accessible, efficient, and personalized for individuals worldwide.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.